TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Clinical trials for TRANSFORMED FOLLICULAR LYMPHOMA (TFL) explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED FOLLICULAR LYMPHOMA (TFL) trials appear
Sign up with your email to follow new studies for TRANSFORMED FOLLICULAR LYMPHOMA (TFL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Tough-to-Treat blood cancers
Disease control Recruiting nowThis trial investigates CRC01, a therapy made from a patient's own immune cells that are genetically modified to recognize and attack cancer cells. It is for adults with large B-cell lymphoma or B-cell acute lymphoblastic leukemia that has returned or not responded to previous tr…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Phase: PHASE1, PHASE2 • Sponsor: Curocell Inc. • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
Engineered immune cells take on tough lymphoma
Disease control Recruiting nowThis study tests a new treatment called TC011, which uses a patient's own immune cells engineered to find and attack lymphoma cells. It is for adults with large B-cell lymphoma that has come back or not responded to at least two prior treatments. The trial will check safety and h…
Matched conditions: TRANSFORMED FOLLICULAR LYMPHOMA (TFL)
Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC